Antimicrobial therapy of sepsis. Recommendations of a working group of the Paul-Ehrlich Society for Chemotherapy;Antimikrobielle therapie der sepsis: Empfehlungen einer arbeitsgruppe der Paul-Ehrlich-Gesellschaft für chemotherapie e.V.

Chemotherapie Journal

Volumn 10, Issue 2, 2001, Pages 43-55

  Bodmann, K F ^a  

^a KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; MEROPENEM; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TEICOPLANIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; AREA UNDER THE CURVE; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG METABOLISM; HOSPITAL INFECTION; SEPSIS; SHORT SURVEY;

EID: 0035062919     PISSN: 09406735     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (43)

1. Intravenous immunoglobulin for treating sepsis and septic shock
2. Septic shock
3. Impact of antibiotic resistance on the treatment of gramnegative Sepsis
4. Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations
5. Septic shock
6. Antimikrobielle Therapie
7. Sir Isaac Newton, sepsis, SIRS, and CARS
8. Sepsis: A new hypothesis for pathogenesis of the disease process
9. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine
10. Procalcitonin und C3a: Nützlich zur Prognose und Verlaufsbeurteilung der Sepsis?
11. Current therapy for sepsis
12. Epidemiologie der Meningokokken-Infektionen
13. Clinical trial results with antithrombin III in sepsis
14. Septicemia in 980 patients at an university hospital in Berlin: Prospective studies during four selected years between 1979 and 1989
15. Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS)
16. Drug-resistant Streptococcus pneumoniae: Rational antibiotic choices
17. Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Chemotherapeutika in Mitteleuropa
18. Prävalenz der Antibiotikaresistenz bei klinisch wichtigen Infektionserregern in Mitteleuropa. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft "Resistenz" in der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 1995
19. Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications
20. Einteilung der Fluorchinolone
21. Strategies to rationalize sepsis management - A review of 4 years' experience in Dundee
22. Miller CE Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care
23. Contemporary issues with bacterial infection in the intensive care unit
24. Epidemiologie von Septikämie-Erregern
25. Wesen und Behandlung der Sepsis
26. Einteilung der Cephalosporine
27. Antibiotic selection for patients with septic shock
28. Treatment of septic shock with immunotherapy
29. Die häufigsten Erreger bei Intensivpatienten mit nosokomialen Infektionen. Ergebnisse des Krankenhaus-Infektions-Surveillance-Systems (KISS)
30. Computergestützte prospektive Erfassung nosokomialer Septikämien in einem Universitätsklinikum
31. Antimicrobial chemoprophylaxis of pneumonia in intensive care patients
32. Management of the critically ill patient with severe sepsis
33. Positionspapier zur Antibiotikatherapie in der Klinik
34. Parenterale Antibiotika bei Erwachsenen
35. Supplemental immune globulins in sepsis: A critical appraisal
36. Treating patients with severe sepsis
37. Scope and limitations of antimicrobial therapy of sepsis in surgery
38. Molecular mechanisms of sepsis
39. Chemotherapy for gram-positive nosocomial sepsis
40. Sepsis and septic shock